Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Renal Cell Carcinoma

Clinical trial condition

Metastatic Renal Cell Carcinoma

Explore clinical trials studying Metastatic Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

125 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Renal Cell Carcinoma trial results

Completed

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

NCT02639182

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Site US01026 Tucson, Arizona, United States

Site US01008 La Jolla, California, United States

Site US01007 Los Angeles, California, United States

Site US01020 Los Angeles, California, United States

View all 26 locations

View Trial Details

Completed

Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC

NCT06607809

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Health Science University Kartal Dr. Lütfi Kirdar City Hospital Istanbul, Kartal, Turkey (Türkiye)

View Trial Details

Completed

The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma

NCT00554515

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

NCT05112627

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer

NCT03829111

Conditions: Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +19 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma

NCT01028638

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: University Medical Centre Groningen Groningen, Netherlands

View Trial Details

Completed

Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and Nivolumab

NCT03126331

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor

NCT02944617

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma

NCT00606866

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

NCT02599324

Conditions: Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Urothelial Carcinoma, +17 more
Locations: Clearview Cancer Institute /ID# 1128-0965 Huntsville, Alabama, United States

Banner MD Anderson Cancer Center /ID# 1128-0802 Gilbert, Arizona, United States

University of Arizona Cancer Center - Tucson /ID# 1128-1546 Tucson, Arizona, United States

Alta Bates Comprehensive Cancer Center /ID# 1128-0135 Berkeley, California, United States

View all 65 locations

View Trial Details